DUBLIN–(BUSINESS WIRE)–The “U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape – Analysis and Forecast, 2019-2030” report has been added to ResearchAndMarkets.com’s providing.
In keeping with this report the U.S. strong tumor testing market was valued at $8,179.7 million in 2019 and is anticipated to develop over $15,396.four million by 2030. The U.S. strong tumor testing market is anticipated to develop at a single-digit compound annual development fee within the forecast interval 2020-2030, aided primarily by the excessive development within the molecular diagnostics market.
The solutions to the next key questions may be derived from this report:
- What are the most important market drivers, challenges, and alternatives within the U.S. strong tumor testing market?
- What are the underlying buildings ensuing within the rising developments throughout the U.S. strong tumor testing market?
- How is every section anticipated to develop within the U.S. strong tumor testing market through the forecast interval, and what’s the estimated income to be generated by every of the segments by the top of 2030?
- What are the important thing developmental methods that are applied by the most important gamers with a purpose to maintain within the aggressive market? What are the important thing regulatory implications in developed and creating areas for strong tumors testing?
- That are the main gamers with vital choices to the U.S. strong tumor testing market? What’s the present market dominance for every of those main gamers?
- What could be the compound development fee witnessed by the main gamers out there through the forecast interval 2020-2030?
- What are the important thing purposes within the U.S. strong tumor testing market? What are the most important segments of those purposes?
- That are the dominant illness areas of the U.S. strong tumor testing market? Which is the fastest-growing illness section within the U.S. strong tumor testing market?
- That are the important thing producers and repair suppliers within the U.S. strong tumor testing market, and what are their contributions? What’s the development potential of every main strong tumor testing resolution supplier?
- What’s the scope of the U.S. strong tumor testing market in several states throughout the U.S.?
- Rising Incidence of Cancers
- Growing Adoption of Inorganic Progress Methods within the Market
- Growing Analysis Funding from Nationwide Most cancers Institute
- Reimbursement Cuts within the U.S.
- Excessive Pricing Strain
- Anticipated Implementation of Affected person Safety and Inexpensive Care Act (PPACA) within the U.S.
- Informatics and Technological Innovation for Bigger Client Base
- Anticipated Enhance within the Adoption of Genetic Testing
Firms Talked about
- ARUP Laboratories
- ASURAGEN, INC.
- Abbott Laboratories
- ArcherDX, Inc.
- Bio-Rad Laboratories, Inc.
- Most cancers Genetics Inc.
- Caris Life Sciences
- F. Hoffmann-La Roche Ltd.
- Genomic Testing Cooperative
- Guardant Well being
- HTG Molecular Diagnostics
- Illumina, Inc.
- Invitae Company
- Invivoscribe, Inc.
- Laboratory Company of America Holdings
- Nanostring Applied sciences
- NeoGenomics Laboratories, Inc.
- Opko Well being
- Private Genome Diagnostics
- QIAGEN N.V.
- Quest Diagnostics Included
For extra details about this report go to https://www.researchandmarkets.com/r/uteun2
— to www.businesswire.com